Clinical Trials Browser

Phase 1/2 × INDUSTRY × tivozanib × Clear all

NCT03136627 2021-12-06

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

Phase 1/2 Completed

Carcinoma, Renal Cell